• Home
  • Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation.

Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation.

Author List
von Achenbach C, Silginer M, Blot V, Weiss WA, Weller M
Publication
Molecular cancer therapeutics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/108814779
Publication Year
2020
PubMed ID
32371586
Publication Title
von Achenbach C, Silginer M, Blot V, Weiss WA, Weller M. Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation. Mol Cancer Ther. 2020 06; 19(6):1328-1339.